Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor

Human Reproduction

Volumn 21, Issue 9, 2006, Pages 2312-2318

  Narvekar, Nitish ^a   Critchley, Hilary O D ^a   Cheng, Linan ^b   Baird, David T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Shanghai Municipal Key Clinical Specialty   (China)

Author keywords

Contraception; Endometrium; Glucocorticoid receptor; Mifepristone; Vascular endothelial growth factor

Indexed keywords

ESTRADIOL; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; VASCULOTROPIN;

ADULT; AMENORRHEA; ARTICLE; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INCIDENCE; LOW DRUG DOSE; MICROVASCULATURE; PROTEIN EXPRESSION; UPREGULATION;

EID: 33749553302     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del182     Document Type: Article

References (53)

1. Albrecht ED, Babischkin JS, Lidor Y, Anderson LD, Udoff LC and Pepe GJ (2003) Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum Reprod 18,2039-2047.
2. Arcuri F, Battistini S, Hausknecht V, Cintorino M, Lockwood CJ and Schatz F (1997) Human endometrial decidual cell-associated 11 beta-hydroxysteroid dehydrogenase expression: Its potential role in implantation. Early Pregnancy 3,259-264.
3. Baird DT, Cameron ST, Critchley HO, Drudy TA, Howe A, Jones RL, Lea RG and Kelly RW (1996) Prostaglandins and menstruation. Eur J Obstet Gynecol Reprod Biol 70,15-17.
4. Baird DT, Brown A, Critchley HO, Williams AR, Lin S and Cheng L (2003a) Effect of long-term treatment with low-dose mifepristone on the endometrium. Hum Reprod 18,61-68.
5. Baird DT, Brown A, Cheng L, Critchley HO, Lin S, Narvekar N and Williams AR (2003b) Mifepristone: A novel estrogen-free daily contraceptive pill. Steroids 68,1099-1105.
6. Bamberger AM, Milde-Langosch K, Loning T and Bamberger CM (2001) The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium. J Clin Endocrinol Metab 86,5071-5074.
7. Belsey EM and Farley TM (1988) The analysis of menstrual bleeding patterns: A review. Contraception 38,129-156.
8. Bigsby RM (1993) Progesterone and dexamethasone inhibition of estrogen-induced synthesis of DNA and complement in rat uterine epithelium: Effects of antiprogesterone compounds. J Steroid Biochem Mol Biol 45,295-301.
9. Brown A, Cheng L, Lin S and Baird DT (2002) Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: A double-blind randomized control trial of 2 and 5 mg per day for 120 days. J Clin Endocrinol Metab 87,63-70.
10. Campbell PS (1978) The mechanism of the inhibition of uterotrophic responses by acute dexamethasone pretreatment. Endocrinology 103,716-723.
11. Chwalisz K, Brenner RM, Fuhrmann UU, Hess-Stumpp H and Elger W (2000) Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium. Steroids 65,741-751.
12. Critchley HO, Kelly RW, Lea RG, Drudy TA, Jones RL and Baird DT (1996) Sex steroid regulation of leukocyte traffic in human decidua. Hum Reprod 11,2257-2262.
13. Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, Slayden OD, Millar MR and Saunders PT (2001) Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 86,1370-1378.
14. Delvin EE, Gagnon L, Arabian A and Gibb W (1990) Influence of calcitriol on prolactin and prostaglandin production by human decidua. Mol Cell Endocrinol 71,177-183.
15. Ferrara N (1999a) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77,527-543.
16. Ferrara N (1999b) Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56,794-814.
17. Ferrara N and Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18,4-25.
18. Fraser IS, Hickey M and Song JY (1996) A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception. Hum Reprod 11(Suppl 2),165-178.
19. Gargett CE, Lederman FL, Lau TM, Taylor NH and Rogers PA (1999) Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium. Hum Reprod 14,2080-2088.
20. Glasier AF, Smith KB, van der Spuy ZM, Ho PC, Cheng L, Dada K, Wellings K and Baird DT (2003) Amenorrhea associated with contraception - an international study on acceptability. Contraception 67,1-8.
21. Greb RR, Heikinheimo O, Williams RF, Hodgen GD and Goodman AL (1997) Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo. Hum Reprod 12,1280-1292.
22. Hapangama DK, Critchley HO, Henderson TA and Baird DT (2002) Mifepristone-induced vaginal bleeding is associated with increased immunostaining for cyclooxygenase-2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium. J Clin Endocrinol Metab 87,5229-5234.
23. Henderson TA, Saunders PT, Moffett-King A, Groome NP and Critchley HO (2003) Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 88,440-449.
24. Hickey M, Lau TM, Russell P, Fraser IS and Rogers PA (1996) Microvascular density in conditions of endometrial atrophy. Hum Reprod 11,2009-2013.
25. Hickey M, Simbar M, Young L, Markham R, Russell P and Fraser IS (1999) A longitudinal study of changes in endometrial microvascular density in Norplant implant users. Contraception 59,123-129.
26. Hicks JJ, Duran-Reyes G and Diaz-Flores M (1994) Effect of dexamethasone as an inhibitor of implantation and embryo development in rat; lysosomal role. Contraception 50,581-589.
27. Illouz S, Boubli L, Lavaut MN, Allasia C and Charpin C (2000) Endometrial response to sexual steroids as assessed by prostaglandin F(2alpha) output in explant culture and hormone receptor expression. Gynecol Obstet Invest 50,43-49.
28. Kelly RW (1996) Inflammatory mediators and parturition. Rev Reprod 1,89-96.
29. Korgun ET, Dohr G, Desoye G, Demir R, Kayisli UA and Hahn T (2003) Expression of insulin, insulin-like growth factor I and glucocorticoid receptor in rat uterus and embryo during decidualization, implantation and organogenesis. Reproduction 125,75-84.
30. Lau TM, Affandi B and Rogers PA (1999) The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. Mol Hum Reprod 5,57-63.
31. Meduri G, Bausero P and Perrot-Applanat M (2000) Expression of vascular endothelial growth factor receptors in the human endometrium: Modulation during the menstrual cycle. Biol Reprod 62,439-447.
32. Moller B, Rasmussen C, Lindblom B and Olovsson M (2001) Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod 7,65-72.
33. Moller B, Lindblom B and Olovsson M (2002) Expression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycle. Acta Obstet Gynecol Scand 81,817-824.
34. Monheit AG and Resnik R (1981) Corticosteroid suppression of estrogen-induced uterine blood flow in nonpregnant sheep. Am J Obstet Gynecol 139,454-458.
35. Narvekar N, Cameron S, Critchley HO, Lin S, Cheng L and Baird DT (2004) Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor. J Clin Endocrinol Metab 89,2491-2497.
36. Nayak NR and Brenner RM (2002) Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J Clin Endocrinol Metab 87,1845-1855.
37. Nayak NR, Critchley HO, Slayden OD, Menrad A, Chwalisz K, Baird DT and Brenner RM (2000) Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: Potential relevance to menstruation. J Clin Endocrinol Metab 85,3442-3452.
38. Neulen J, Zahradnik HP, Flecken U and Breckwoldt M (1989) The effect of cortisol on the synthesis of prostaglandins (PGF2 alpha, PGE2) by human endometrial fibroblasts in vitro with and without addition of estradiol-17 beta or progesterone. Prostaglandins 37,587-595.
39. Oliveira-Ribeiro M, Petta CA, De Angelo Andrade LA, Bahamondes L and Hidalgo MM (2004) Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system. Hum Reprod 19,1778-1784.
40. Pakrasi PL, Cheng HC and Dey SK (1983) Prostaglandins in the uterus: modulation by steroid hormones. Prostaglandins 26,991-1009.
41. Rees MC, Heryet AR and Bicknell R (1993) Immunohistochemical properties of the endothelial cells in the human uterus during the menstrual cycle. Hum Reprod 8,1173-1178.
42. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE and Stewart PM (1998) Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab 83,1325-1335.
43. Salamonsen LA (1996) Matrix metalloproteinases and their tissue inhibitors in endocrinology. Trends Endocrinol Metab 7,28-34.
44. Schatz F, Markiewicz L and Gurpide E (1986) Hormonal effects of PGF2 alpha output by cultures of epithelial and stromal cells in human endometrium. J Steroid Biochem 24,297-301.
45. Schindl M, Birner P, Obermair A, Kiesel L and Wenzl R (2001) Increased microvessel density in adenomyosis uteri. Fertil Steril 75,131-135.
46. Small GR, Hadoke PW, Sharif I, Dover AR, Armour D, Kenyon CJ, Gray GA and Walker BR (2005) Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Proc Natl Acad Sci USA 102,12165-12170.
47. Smith SK (2001) Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab 12,147-151.
48. Snyder DS and Unanue ER (1982) Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol 129,1803-1805.
49. Song JY, Markham R, Russell P, Wong T, Young L and Fraser IS (1995) The effect of high-dose medium- and long-term progestogen exposure on endometrial vessels. Hum Reprod 10,797-800.
50. Spitz IM and Bardin CW (1993) Clinical pharmacology of RU 486 - an antiprogestin and antiglucocorticoid. Contraception 48,403-444.
51. Sugino N, Kashida S, Karube-Harada A, Takiguchi S and Kato H (2002) Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 123,379-387.
52. Torry DS, Holt VJ, Keenan JA, Harris G, Caudle MR and Torry RJ (1996) Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril 66,72-80.
53. Wang H, Critchley HO, Kelly RW, Shen D and Baird DT (1998) Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol Hum Reprod 4,407-412.